English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsFelony charges

    Felony Charges

    Jump to
    • Trump's drumbeat of lies about the 2020 election keeps getting louder. Here are the facts

      Trump's drumbeat of lies about the 2020 election keeps getting louder. Here are the facts

      Here are the facts about Trump's loss in the last presidential election.

    • Ranbaxy jumps 30%; street cheers US base business growth

      Ranbaxy jumps 30%; street cheers US base business growth

      Analysts say the company's 26 percent sequential growth in US business was a big positive, and a stock re-rating was on the cards following the improvement visible in its base business.

    • Ranbaxy jumps over 8% on April-June US sales

      Ranbaxy jumps over 8% on April-June US sales

      The US results were a relief after Ranbaxy shares had tumbled 36 percent as of Wednesday's close since the drug maker pleaded guilty to US felony charges related to drug safety and agreed to pay USD 500 million in settlement.

    • UBS upgrades Ranbaxy to 'buy' from 'sell'

      UBS upgrades Ranbaxy to 'buy' from 'sell'

      Brokerage firm UBS upgraded Ranbaxy Labs to 'buy' from 'sell'. It said that the valuations had become attractive after the sharp decline in shares on regulatory concerns.

    • Ranbaxy slumps on Mohali plant under USFDA watch reports

      Ranbaxy slumps on Mohali plant under USFDA watch reports

      The stock hit a near 4-year low after a news report said the US FDA may have issued a form 483 to its Mohali facility. The company has already pleaded guilty to felony charges related to manufacturing practises at its Dewas and Paonta Sahib plants.

    • Ranbaxy down 2% on fears of backlash from doctors

      Ranbaxy down 2% on fears of backlash from doctors

      According to a newspaper report Jaslok Hospital in Mumbai has advised its doctors to stop using Ranbaxy's drugs. The report comes after Ranbaxy pleaded guilty in the US to felony charges related to manufacturing at two of its plants, earlier this month.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347